Price
No data yet.
Social Signal Score
Revenue
$32.01M+935.01%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Sean T. Saint
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 422
- Beta
- 3.36
- Country
- US
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- 13.34
Financials
Revenue
$32.01M+935.0%Net Income
$-23.40MEBITDA
$-24.46MFree Cash Flow
$-15.66MEPS (diluted)
$-0.53Shares Outstanding (diluted)
44.55M+3.9%Operating Expenses
$44.48MCash & Debt
$180.49MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $100.25M | $-73.20M | $-1.81 |
| 2024 | $65.12M | $-54.76M | $-1.28 |
| 2023 | $11.99M | $-44.10M | $-1.03 |
| 2022 | $179.0K | $-64.75M | $-1.51 |
Valuation
BBNXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100Social Signal Score
Mentions (1)
- Newsbusinesswire.com·6h ago·Neutral
Beta Bionics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BBNX LOS ANGELES--(BUSINESS WIRE)---- $BBNX--Beta Bionics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BBNX.
View source ↗
Earnings
Tue, Oct 27(in 7 weeks)
Consensus estimate $-0.55 per share
Typical surprise +8.8% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Jul 29$-0.53 vs $-0.58beat
- Tue, Apr 21$-0.49 vs $-0.53beat
- Tue, Feb 17$-0.30 vs $-0.42beat
- Tue, Oct 28$-0.33 vs $-0.45beat
- Tue, Jul 29$-0.39 vs $-0.51beat
- Tue, May 6$-0.52 vs $-0.51miss
Estimates and results for BBNX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by BBNX officers and directors.
- Bought
- —
- Sold
- $4.0m
0 trades
52 trades
- Saint Seansold
- Hopman Marksold
- Russell Steven Jonsold
- Mensinger Mikesold
- Feider Stephensold
- Saint Seansold
- Feider Stephensold
- Feider Stephensold
48 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.